Cargando…
Therapeutic Modulation of Apoptosis: Targeting the BCL-2 Family at the Interface of the Mitochondrial Membrane
A vast portion of human disease results when the process of apoptosis is defective. Disorders resulting from inappropriate cell death range from autoimmune and neurodegenerative conditions to heart disease. Conversely, prevention of apoptosis is the hallmark of cancer and confounds the efficacy of c...
Autores principales: | Nemec, Kathleen N., Khaled, Annette R. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Yonsei University College of Medicine
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615374/ https://www.ncbi.nlm.nih.gov/pubmed/18972587 http://dx.doi.org/10.3349/ymj.2008.49.5.689 |
Ejemplares similares
-
Biological properties of the BCL-2 family protein BCL-RAMBO, which regulates apoptosis, mitochondrial fragmentation, and mitophagy
por: Kataoka, Takao
Publicado: (2022) -
New dimension in therapeutic targeting of BCL-2 family proteins
por: Besbes, Samaher, et al.
Publicado: (2015) -
Intrinsically Connected: Therapeutically Targeting the Cathepsin Proteases and the Bcl-2 Family of Protein Substrates as Co-regulators of Apoptosis
por: Soond, Surinder M., et al.
Publicado: (2021) -
BCL-2 family isoforms in apoptosis and cancer
por: Warren, Chloe F. A., et al.
Publicado: (2019) -
Ancient and conserved functional interplay between Bcl-2 family proteins in the mitochondrial pathway of apoptosis
por: Popgeorgiev, Nikolay, et al.
Publicado: (2020)